Netherlands Archives

News and Trends 6 Dec 2019

Dutch Startup Gets €9M to Create First Lab-Grown Pork Prototype

Dutch startup Meatable has raised €9M in a seed round that will allow the company to host a tasting of its first prototype of lab-grown pork by summer 2020. The fundraising was led by the German VC BlueYard Capital, which had participated in Meatable’s previous €3M round last year. New investors include business angels Albert […]

December 6, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 7 Nov 2019

Avantium Builds 10-Ton Demonstration Plant to Produce Bioplastics

The Dutch bioplastics company Avantium has opened a demonstration plant capable of producing 10 tons per year of mono-ethylene glycol (MEG), a compound used to make plastics, using plants as the starting material. Construction of Avantium’s plant began at Chemie Park Delfzijl, the Netherlands, last year. The plant will extract carbohydrates from agricultural waste and […]

November 7, 2019 - 2 minutesmins - By Jonathan Smith

delft university Planet bio business incubator

News and Trends 14 Oct 2019

Dutch Incubator Launched to Scale up Industrial Biotechs

A collaboration involving the Dutch company DSM and other organizations in the Netherlands has launched Planet B.io, an incubator aimed at scaling up technology developed by industrial biotech startups such as the lab-grown meat developer Meatable. Planet B.io is based at the Biotech Campus Delft, the Netherlands, and contains a total of 3,000 m² of office […]

October 14, 2019 - 2 minutesmins - By Jonathan Smith

More News! 11 Oct 2019

RNA Therapy Improves Vision in Untreatable Genetic Blindness

A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the vision of people with Leber’s congenital amaurosis, a rare genetic disease for which there is no treatment. The RNA drug, called sepofarsen, is designed to treat people with a specific mutation in a gene […]

October 11, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

khondrion netherlands melas syndrome inherited diseases

Startup Scout 20 Sep 2019

This Biotech Targets Mitochondria to Treat Inherited Diseases

As we come to the end of the global Mitochondrial Disease Awareness Week, it’s time to visit Khondrion. This Dutch company is developing drugs to treat rare diseases such as MELAS syndrome by targeting defective mitochondria. Mission: To develop small molecule drugs able to treat Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) syndrome. This […]

September 20, 2019 - 3 minutesmins - By Jonathan Smith

breathomix breath diagnostics lung cancer

News and Trends 19 Sep 2019

Dutch ‘Electronic Nose’ Predicts Cancer Immunotherapy Success

A diagnostic device measuring chemicals in the breath, developed by the Dutch company Breathomix, was able to identify lung cancer patients that wouldn’t respond to cancer immunotherapy with unprecedented accuracy. Researchers at the University of Amsterdam tested the device on 143 lung cancer patients, who were going to receive immunotherapy in the form of the […]

September 19, 2019 - 2 minutesmins - By Jonathan Smith

More News! 11 Sep 2019

Dutch Company Raises €60M to Treat Inherited Inflammatory Disease

The Dutch pharmaceutical company Pharvaris has raked in €60M in a Series B round to fund the clinical development of the first oral treatment for hereditary angioedema, a condition that causes swelling in the limbs and airways. The Series B round will fuel the clinical progress of Pharvaris’ oral small molecule treatment for hereditary angioedema, […]

September 11, 2019 - 2 minutesmins - By Jonathan Smith

graphene bacteria rochester delft university

News and Trends 15 Jul 2019

Dutch-US Scientists Use Bacteria to Produce Graphene for Electronics

An international group of researchers has made graphene more affordably and with a lower environmental impact than current chemical methods by using bacteria. Graphene is a very strong and conductive material that could revolutionize electronics and engineering. However, producing graphene in large quantities requires lots of energy and involves toxic chemicals, such as hydrazine, which […]

July 15, 2019 - 2 minutesmins - By Jonathan Smith

lupus autoimmune disease neutrophil citryll

News and Trends 4 Jul 2019

Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A

The Dutch biotech Citryll has raised €15M to develop antibodies that could fight autoimmune and inflammatory diseases more effectively than current treatments by inhibiting the innate immune system. The Series A funds will be used to launch the clinical development of Citryll’s lead antibody, which is designed to treat the autoimmune condition lupus. The money […]

July 4, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 19 Jun 2019

Scientists Grow Head and Neck Cancer Organoids to Personalize Chemotherapy

A team of Dutch researchers has developed the first 3D organoids from patients’ head and neck cancer cells that can be kept alive for a long time, giving physicians a model to test which cancer treatments are the most effective for each patient. Head and neck cancer is an aggressive disease that often requires harsh […]

June 19, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 18 Jun 2019

Dutch Biotech Boosts Hepatitis B Vaccine Effectiveness

Phase II results from Dutch biotech CyTuVax show its enhanced hepatitis B vaccine reduces non-responders by 13%. Around 15% of people receiving vaccines for hepatitis B fail to produce antibodies that protect them against the infection. These non-responders are often given more injections of the vaccine in an attempt to trigger the immune system, but […]

June 18, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 May 2019

First Potential Gene Therapy for Hemophilia B Restores Blood Clotting in Phase II

A gene therapy developed by the Dutch biotech uniQure increased the activity of a blood clotting protein enough to stop bleeds in patients with the blood disorder hemophilia B. Hemophilia B is a rare genetic condition in which patients have a mutation in the blood clotting protein factor IX (FIX), reducing its activity below 6% […]

May 14, 2019 - 3 minutesmins - By Jonathan Smith

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us